ArticleJournal of Cancer2021

Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1.

Dongdong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.